InvestorsHub Logo
Followers 212
Posts 22787
Boards Moderated 1
Alias Born 08/12/2015

Re: noreen post# 35521

Tuesday, 06/27/2017 3:55:54 PM

Tuesday, June 27, 2017 3:55:54 PM

Post# of 113775
I BELIEVE THE REPORT INCLUDES THESE ALSO? These numbers are sec reported I believe


 
?

Arimidex® $232M in 2016

?

Femara® $380M in 2014

?

Casodex® $247M in 2016

?

Propecia® $183M in 2015

 

Sunshine Canada is currently in the process of securing a Drug Identification Number (“DIN”) for each of these products from Health Canada. We are also working on finding an appropriate facility and obtaining a Drug Establishment License (“DEL”) from Health Canada. Upon receipt of the DEL and DIN’s, we will be able to accept orders for our own label SBI-Anastrozole, SBI-Letrozole, SBI-Bicalutamide and SBI-Finasteride. We cannot estimate the timing in our obtaining either the DIN or DEL due to variables involved that are out of our control. The Figure below shows our 30-Pill blister pack of Anastrozole

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News